Clinical Trial

The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.

Study acronym: HIDVID
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study will be to assess the effectiveness of monitored vit D supplementation in a population of preterm infants and to identify whether the proper vit D supplementation in preterm infants can reduce the incidence of neonatal sepsis and incidence of metabolic bone disease.
Trial Details
NCT Number NCT06199102
Lead Sponsor Princess Anna Mazowiecka Hospital, Warsaw, Poland
Collaborators: Medical University of Warsaw
Conditions Vitamin D Deficiency, Osteopenia of Prematurity, Nephrolithiasis, Metabolic Bone Disease, Late-Onset Neonatal Sepsis
Enrollment 130 participants
Start Date 2024-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-10